Linkage of clinical practice research datalink (CPRD) to the national cancer data registry (NCDR) database for the study: hormone therapy in relation to risks of second cancers and mortality among…
Ended Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Department Of Health UEI CGFMM2DJPAJ3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $15,281.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541713 Research and Development in Nanotechnology
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$15,281 | |
| Original award | $15,281 |
About this award
The National Cancer Institute issued a BPA call to the Department of Health (Medicines & Healthcare Products Regulatory Agency) on March 24, 2021, for linkage of Clinical Practice Research Datalink (CPRD) data to the National Cancer Data Registry (NCDR) database to support a study of hormone therapy in relation to risks of second cancers and mortality. The call was issued under the National Cancer Institute Blanket Purchase Agreement, which provides firm fixed price access to United Kingdom Clinical Practice Research Datalink databases and linkages to other registries supporting epidemiological cancer research. Performance occurs in Rockville, Maryland. The call ceiling is $15,281.00 with an ultimate completion date of March 23, 2022. This award administratively de-obligates unexpended fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for those funds.
Description
Linkage of clinical practice research datalink (CPRD) to the national cancer data registry (NCDR) database for the study: hormone therapy in relation to risks of second cancers and mortality among women and men.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Department Of Health by National Cancer Institute (National Institutes of Health) on March 24, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $0 on 75N91021F00001. Its potential value, with all options, is $15,281.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a BPA call under 75N91020A00003, a blanket purchase agreement.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award